CD8A and cancer: Our data suggest that adenoviral antigens are processed through autophagy and presented predominantly via MHC class II.[10] It has been reported that MHC class II presentation of antigens leads first to the activation of CD4+ cells, and then to stimulation of CD8+ cytotoxic T cells, that will ultimately execute the anti-cancer activity [35].